Did you read the article?
It's not odd to you the way they broke out the data? All you got was what happened in the worst 25% of days.... That and the fact that they present data from 2 separate trials together should be a big red flag.
There is only 1 hedge fund and they bought everything below $4... they won't be adding here.
The article was spot on... They data mined to make it look ok, but when your analysis relies on the worst 25% of days you know something is up.
What was going on the other 75% of the time?
You guys can talk about DMJR all you want, but it won't change the fact that the fully diluted outstanding shares will be at 100 million.
For the commitment that DMJR has made, that is pretty good. A lot of companies in IMSC's position would have hundreds of millions of shares outstanding, so please don't try to act like 100 million is a big deal.
Plus, they had warrants at 8 cents and the pps still ran to 1.80, so please stop with the "they'll kill the pps any chance they get" stuff.
You're living in a dream world...
I hope it happens, but it definitely isn't "realistic"... Even a reversal takes close to a year.
Feel free to point to a situation where the FDA reversed their decision out of no where... I'd definitely like to see one and feel as hopeful as you.
It's the only product that meets the standards set forth by the US government. You've got to decide what to make of that, but it would be hard to spin it as a negative....though some have tried.
If it makes you feel any better, the entire thing has been heavily manipulated. The action yesterday was because Baker bros bought 2 million shares under $4?! Funny how that corresponds with all of those upgrades.
It may go higher, but it's a great short, if you're allowed to short.
Investors are excited that they get the chance to ask management questions... News drives the pps when you aren't selling a product.
Plus, they've clearly sold off in anticipation of this news. Titan was blindsided, so things are a bit different.
I'm sure the pps will spike when Titan releases some actual news.
Yeah, I'm going to write another article because I have come up with an argument to beat it and beat it easily (with existing data).
It's easier to do it there, but I would make it a board post if they let me use links.
Still, the FDA may stand firm...
Maybe, but I've looked at that word, and other addiction words, many many many times over the last 3-4 years and I still don't know how to spell them some times.
On top of that, I was in an accident about a month ago and I couldn't even tell you all of the meds i've been on since. That is with me keeping fairly decent records (due to insurance purposes).
The point is, these medical terms are hard to nail down even when you are experienced. I tend to look at anyone who claims to be a doctor or __________(insert the profession here that makes you an expert on any given stock), but maybe he is genuine...
I'm fairly certain most patients either don't get high, have to use A LOT of drugs to get high, or get a very slight high if they use while on Suboxone.
Of course, there are exceptions.
He doesn't know what Probuphine does. He knows what Buprenorphine does and assumes that it translates to Probuphine because it is the same drug.
The delivery method and the amount of drug getting to the receptors is what the FDA is questioning.
The FDA didn't question anything about Suboxone or Subutex (Suboxone minus the naloxone). They even threw in something along the lines of "this clearly works"...
accessdata DOT fda DOT gov/drugsatfda_docs/nda/2002/20-733_Subutex_Medr_P6 DOT pdf